Natbury Life Care: Meeting Underpad Market Needs With Precision & Reliability

Satish Bhagle, Managing Director

Satish Bhagle

Managing Director

The high-quality healthcare underpads market is vital to the hygiene products industry, driven by increasing demand for reliable and comfortable in­continence solutions across healthcare facilities, nursing homes, and individual consumers. The growth is primar­ily fueled by the aging global population and the need for effective incontinence management products that provide comfort and hygiene, especially for older people. However, manufacturers must grapple with continuous innovation, high raw material costs, and regulatory requirements. Ad­dressing these market challenges with a blend of innova­tion, quality, and strategic foresight is Natbury Life Care.

Founded in 2017, Natbury Life Care Private Limited has swiftly risen to prominence as one of the leading manufacturers of high-quality healthcare underpads. With a commitment to producing baby, adult, and pet pads, the company has set a standard for reliability and quality in its sector. “Our raw materials are sourced from market leaders in Europe as well as some renowned local manufacturers to create a world-class product mix to offer our esteemed customers the best product value,” says Satish Bhagle, Managing Director, Natbury Life Care. The approach ensures the highest quality standards and allows the flexibility to create custom-designed underpads with unique properties and features. Whether it is specific absorbance, custom sizes, or specialized pad layers, Natbury Life Care’s products are tailored to meet the exact needs of its clients.

Natbury Life Care has responded to the demand for incontinence products that combine high absorbency with comfort and discretion by developing a unique five-layer construction that prevents location shifts and enhances absorbency. Its fully automatic imported machines, combined with minimal manual handling, ensure consistent quality and high productivity, enabling the company to meet the demands of timely delivery without compromising on the excellence of its products. Capable of churning out 60 million pieces per annum, the company’s production capacity is a testament to its operational efficiency and commitment to meeting market needs. The advanced manufacturing capability offers reliable, on-time delivery, a critical factor for their clients in the healthcare sector. The company’s dedication to maintaining stringent quality standards is evidenced by its ISO 9002:2015, CE, and WHO-GMP certifications, underscoring its adherence to globally recognized benchmarks. Moreover, the company’s emphasis on antibacterial and antifungal finishes ensures that its products provide comfort, help maintain hygiene, and prevent infections, thereby delivering a comprehensive solution to end-users.

Flexibility is crucial in a market where customer preferences can change rapidly, and the ability to quickly adapt to these changes is a valuable asset. Natbury Life Care offers short sampling and production lead times, coupled with lower minimum order quantities compared to its competitors. In addition, the company’s focus on strategic planning aims to enhance its production capacity further, with a target to achieve 100 million bed pads production in the next 2-3 years.

Whether it is specific absorbance, custom sizes, or specialized pad layers, Natbury Life Care’s products are tailored to meet the exact needs of its clients

Satish Bhagle, Managing Director

From Local Success to Global Reach

The firm’s global customer base reflects its product quality and reliability. Since its inception, the company has not only catered to the domestic Indian market but also expanded its reach to international markets. Its three-way selling channel—direct to customers, through agents, and third-party merchant exports—ensures a broad distribution network. Some of the leading hospital chains in India use Natbury Life Care products under private labels, highlighting the trust and credibility the company has built in the healthcare sector. Its direct buyers, including Torrent Pharma (India), Arise Q1 (US), and Standard Fiber LLC (US), further underscore their global footprint and reputation.

The firm has successfully penetrated markets in Kuwait, Taiwan, Ukraine, Singapore, Sri Lanka, and Myanmar through the merchant exports model. A well-established supply chain and a robust procurement process support the extensive reach. The company’s selection of vendors is based on stringent criteria, including past track records, manufacturing techniques, delivery consistency, and packing standards. The rigorous approach ensures Natbury Life Care products meet customer expectations consistently and within the stipulated time frame.

At the core of Natbury Life Care’s success is its team of highly qualified professionals, including procurement & product development experts, quality auditors, and engineers. These individuals drive the technical and product development teams, ensuring the company remains at the forefront of innovation in the hygiene products industry. Parallel to this, the marketing team stays abreast of global trends, continually bringing new concepts and ideas to add value to the end customer.

The company’s dedication to continuous improvement extends to its workforce. It believes in nurturing and developing every individual within the organization, from the labor level to the executive level. By encouraging employees to create new ideas and fostering a culture of innovation, the company constantly evolves and improves its offerings.

Natbury Life Care exemplifies quality, innovation, and customer-centricity in hygiene products. Its strategic approach to sourcing, manufacturing, and distribution, combined with a strong focus on quality and innovation, positions it as a reliable partner for customers, investors, and partners alike. As it continues to expand its global footprint and enhance its production capabilities, Natbury Life Care is well-poised to meet the market's growing demands and set new benchmarks in the industry.

© 2024 India Pharma Outlook. All Rights Reserved.